Xenografts
Research on Xenografts Reported by Scientists at University of California
Published in Biotech Business Week, April 11th, 2011
2011 APR 11 -- In this recently published article, scientists in Sacramento, United States conducted a study "To determine if a human bladder cancer-specific peptide named PLZ4 can target canine bladder cancer cells. The binding of PLZ4 to five established canine invasive transitional cell carcinoma (TCC) cell lines and to normal canine bladder urothelial cells was determined using the whole cell binding assay and an affinitofluorescence assay."
"The WST-8 assay was performed to determine whether PLZ4 affected cell viability. In vivo tumor-specific homing/targeting property and biodistribution of PLZ4 was performed in a mouse xenograft model via tail vein...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Biotechnology
Mres Announces Resumption of The Buyout Offer at $0.15 from Auric - Biotechnology
Angiotech Pharmaceuticals, Inc. Extends Exchange Offer for Senior Floating Rate Notes - Biotechnology
Contaminated IV Solution Points to Need for USP 797 Implementation and Compliance - Biotechnology
HighRes Biosolutions awarded by Massachusetts Life Sciences Center for job creation - Hip Replacements
Hip Implant Recall Questions -- FREE Report Answers Common Questions And Helps Hip Replacement Recall Victims Get Compensation - Hip Replacements
Hip Replacement Recipients Encouraged to Obtain Their Medical Records - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
